The Cimicifuga preparation BNO 1055 vs. conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers.

@article{Wuttke2003TheCP,
  title={The Cimicifuga preparation BNO 1055 vs. conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers.},
  author={Wolfgang Wuttke and Dana Seidlov{\'a}-Wuttke and Christoph Gorkow},
  journal={Maturitas},
  year={2003},
  volume={44 Suppl 1},
  pages={S67-77}
}
OBJECTIVES In the present study, therapeutic effects of the Cimicifuga racemosa preparation CR BNO 1055 (Klimadynon/Menofem) on climacteric complaints, bone metabolism and endometrium will be compared with those of conjugated estrogens (CE) and placebo. The question whether CR BNO 1055 contains substances with selective estrogen receptor modulator (SERM) activity will be investigated. METHODS Sixty-two evaluable postmenopausal women were included in the double-blind, randomized, multicentre… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 78 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 33 references

Evaluation der klimakterischen beschwerden (menopause rating scale (MRS)) zentralblatt für gynäkologie

  • GA Hauser, IC Huber, PJ Keller, C Lauritzen, HPG. Schneider
  • 1994
Highly Influential
3 Excerpts

Phytotherapeutikum beeinflusst atrophisches vaginalepithel: doppelblindversuch Cimicifuga vs Östrogenpräparat (phytopharmacon influences atrophic vaginal

  • W. Stoll
  • Maturitas
  • 2003
2 Excerpts

Similar Papers

Loading similar papers…